![Neil Bodick](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Neil Bodick
Plus aucun poste en cours
Profil
Neil Bodick is the founder of Flexion Therapeutics, Inc. which was founded in 2007.
He held the title of Chief Scientific Officer from 2017 to 2020.
Dr. Bodick's former job was as the Chief Operating & Medical Officer at Lilly Research Laboratories from 2000 to 2007.
He was also an Assistant Professor at Perelman School of Medicine.
Dr. Bodick has a doctorate from The Trustees of Columbia University in The City of New York and Albert Einstein College of Medicine, Inc. He also has an undergraduate degree from Cornell University and an MBA from The Wharton School of the University of Pennsylvania.
Anciens postes connus de Neil Bodick
Sociétés | Poste | Fin |
---|---|---|
FLEXION THERAPEUTICS, INC. | Fondateur | 03/01/2020 |
Lilly Research Laboratories
![]() Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Directeur des opérations | 01/01/2007 |
Perelman School of Medicine | Corporate Officer/Principal | - |
Formation de Neil Bodick
The Trustees of Columbia University in The City of New York | Doctorate Degree |
Cornell University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Flexion Therapeutics, Inc.
![]() Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
Lilly Research Laboratories
![]() Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |